USPTO 2015–2025 USPTO PatentsView US Corporation

Shifamed Holdings, Llc

USPTO PatentsView assignee record - 79 granted patents across 17 technology areas, active 2016–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE).

Compiled by PlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

20.5

Avg claims per patent

+458%

5-year filing velocity

The verdict

Shifamed holds 79 US patents across 17 technology areas, rank #4,489 of 50,000 tracked assignees.

#4,489
of 50,000 US assignees by volume: Top 9%
by Innovation Score (53.7/100): 20.5
avg claims per patent: +458%
filing velocity, last 5 yrs

Portfolio overview

Shifamed Holdings, Llc has been granted 79 US utility patents between 2016 and 2025, placing Shifamed Holdings, Llc at rank #4,489 across all assignees tracked by PlainPatent. This portfolio spans 17 distinct Cooperative Patent Classification (CPC) subclasses, averaging 20.5 claims per patent with primary concentration in A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE). As a US Corporation, Shifamed Holdings, Llc is one of the more focused assignees in the PatentsView dataset. By volume, Shifamed sits between Ranpak Corp. (79 patents, rank #4,485) and The University Court Of The University Of Edinburgh (79 patents, rank #4,493) - the closest US assignees by grant volume. The composite Innovation Score of 53.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 67 grants, compared with 12 in the 2015–2019 window, a +458% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Shifamed Holdings, Llc's 20.5 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 17 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Shifamed Holdings, Llc against peers pursuing similar technology classes.

Ranpak

79
SK Siltron

79
SK ie technology

79
Savant Systems

79
TE Connectivity N…

79
Tesla Motors

79
Thales Avionics

79
The University Co…

79
Shifamed Holdings ◀

79

What this shows Shifamed holds 79 patents at rank #4,489, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Shifamed

By rank, the assignees closest to #4,489 in granted patent volume.

Leaders in A61F (Filters Implantable INTO Blood Vessels)

Other assignees with the most granted patents in Shifamed's primary technology class.

Shifamed's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

54 Top 9% higher than 91% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Shifamed Holdings, Llc patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	1.3%
2017	4	5.1%
2018	1	1.3%
2019	6	7.6%
2020	5	6.3%
2021	9	11.4%
2022	8	10.1%
2023	14	17.7%
2024	13	16.5%
2025	18	22.8%

Which technologies does Shifamed Holdings, Llc patent most?

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 47

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 41

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 23

B29D - PRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE 7

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 6

C08L - COMPOSITIONS OF MACROMOLECULAR COMPOUNDS 5

B29C - SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING 3

B29K - INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR ; MOULDS, ; REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS 3

B32B - LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM 3

B21D - WORKING OR PROCESSING OF SHEET METAL OR METAL TUBES, RODS OR PROFILES WITHOUT ESSENTIALLY REMOVING MATERIAL; PUNCHING METAL 1

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 1

E02D - FOUNDATIONS; EXCAVATIONS; EMBANKMENTS ; UNDERGROUND OR UNDERWATER STRUCTURES 1

G02B - OPTICAL ELEMENTS, SYSTEMS OR APPARATUS 1

G01S - RADIO DIRECTION-FINDING; RADIO NAVIGATION; DETERMINING DISTANCE OR VELOCITY BY USE OF RADIO WAVES; LOCATING OR PRESENCE-DETECTING BY USE OF THE REFLECTION OR RERADIATION OF RADIO WAVES; ANALOGOUS ARRANGEMENTS USING OTHER WAVES 1

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 1

Top 15 of 17 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Complex

Velocity Accelerating

Where it ranks

Overall rank by patents

#4,489

Across all tracked assignees

Innovation Score

53.7 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Shifamed Holdings, Llc hold?

Shifamed Holdings, Llc holds 79 US granted patents filed between 2016 and 2025, spanning 17 technology areas.

What is Shifamed Holdings, Llc's Innovation Score?

Shifamed Holdings, Llc has an Innovation Score of 53.7 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Shifamed Holdings, Llc focus on?

Shifamed Holdings, Llc's top technology area is A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS) with 47 patents. The company has filed patents in 17 CPC subclasses total.

Is Shifamed Holdings, Llc's patent filing rate increasing or decreasing?

Shifamed Holdings, Llc's recent filing velocity is +458% compared to the prior five-year period. This indicates accelerating innovation.

What does claim depth mean for Shifamed Holdings, Llc's patents?

Shifamed Holdings, Llc's patents average 20.5 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.

How is the Shifamed Holdings, Llc patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Shifamed's 79 grants land it in the top 9% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Shifamed ranks #4,489 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61F - see who else leads that technology area. A61F leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.